Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers

Clinical Pharmacokinetics

Volumn 44, Issue 7, 2005, Pages 753-765

  Donovan, Jennifer L ^a   DeVane, C Lindsay ^a   Malcolm, Robert J ^b   Mojsiak, Jurij ^c   Nora Chiang, C ^c   Elkashef, Ahmed ^c   Taylor, Robin M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MUSC Center for Drug and Alcohol Programs   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MODAFINIL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ADULT; ANESTHETICS, LOCAL; AREA UNDER CURVE; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT SELECTION; SINGLE-BLIND METHOD;

EID: 22244489421     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200544070-00006     Document Type: Article

References (25)

1. Simpson DD, Joe GW, Broome KM. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 2002; 59: 538-44
2. de Lima MS, Soares GD, Reisser AAP, et al. Pharmacological treatment of cocaine dependence: a systematic review. Addiction 2002; 97: 931-49.
3. Dackis CA, Lynch KG, Yu E, et al. Modafinil and cocaine: a double-blind placebo-controlled drug interaction study. Drug Alcohol Depend 2003; 70: 29-37
4. Myrick H, Malcolm RJ, Taylor B, et al. Modafinil: preclinical, clinical, and post marketing surveillance: a review of abuse liability issues. Ann Clin Psychiatry 2004; 16 (2): 101-9
5. Malcolm RJ, Moak DH, Book SW, et al. Clinical applications of modafinil in stimulant abusers: low abuse potential. Am J Addict 2002; 11: 247-9
6. de la Mora MP, Aguilar-Garcia A, Ramon-Frias T, et al. Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus. Neurosci Lett 1999; 259: 181-5
7. Ferraro L, Antonelli T, O'Connor WT, et al. Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry 1997; 42: 1181-3
8. Mignot E, Nishino S, Guilleminault C, et al. Modafinil binds to the dopamine uptake carriet site with low affinity. Sleep 1994; 17: 436-7
9. Wisor JP, Nishino S, Sora I, et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787-94
10. Rush CR, Kelly TH, Hays LR, et al. Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol 2002; 13: 105-15
11. Jasinski DR, Kovacevic-Ristanovic R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 2000; 23: 149-56
12. Moachon G, Matinier D. Simultaneous determination of modafinil and its acid metabolite by high-performance liquid chromatography in human plasma. J Chromatogr B Biomed Appl 1994; 654: 91-6
13. Robertson P, Hellriegel ET, Arora S, et al. Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. Clin Pharmacol Ther 2002; 71: 46-56
14. Cook CE, Jeffcoat R, Perez-Reyes M. Pharmacokinetic studies of cocaine and phencyclidine in man. In: Barnett G, Chiang CN, editors. Pharmacokinetics and pharmacodynamics of psychoactive drugs. Foster City (CA): Biomedical Publications, 1985: 49-75
15. Warner A, Norman AB. Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: a clarification. Ther Drug Monit 2000; 22: 266-70
16. Ladona MG, Gonzalez ML, Rane A, et al. Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression. Life Sci 2000; 68: 431-43
17. Pellinen P, Stenback F, Kojo A, et al. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology 1996; 23: 515-23
18. Overall JE, Gorham DR. The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988; 24: 97-9
19. Lin SN, Moody DE, Bigelow GE, et al. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma. J Anal Toxicol 2001; 25: 497-503
20. Donovan JL, Malcolm RJ, Markowitz JS, et al. Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies. Ther Drug Monit 2003; 25: 197-202
21. Wong YN, Wang L, Hartman L, et al. Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol 1998; 38: 971-8
22. Inaba T. Cocaine: pharmacokinetics and biotransformation in man. Can J Physiol Pharmacol 1989; 67: 1154-7
23. Khan M, Gupta PK, Cristie R, et al. Determination of pharmacokinetics of cocaine in sheep by liquid chromatography. J Pharm Sci 1987; 76: 39-43
24. Roerig DL, Kotrly KJ, Dawson CA, et al. First-pass uptake of verapamil, diazepam, and thiopental in the human lung. Anesth Analg 1989; 69: 461-6
25. Upton RN, Doolette DJ. Kinetic aspects of drug disposition in the lungs. Clin Exp Pharmacol Physiol Suppl 1999; 26: 381-91